4//SEC Filing
Hombeck Torsten 4
Accession 0000950170-25-043934
CIK 0001541157other
Filed
Mar 23, 8:00 PM ET
Accepted
Mar 24, 5:00 PM ET
Size
9.4 KB
Accession
0000950170-25-043934
Insider Transaction Report
Form 4
Transactions
- Award
Stock Option (Right to Buy)
2025-03-20+300,000→ 300,000 totalExercise: $1.50Exp: 2035-03-20→ American Depositary Shares representing Ordinary Shares (300,000 underlying) - Award
Stock Option (Right to Buy)
2025-03-20+200,000→ 200,000 totalExercise: $1.50Exp: 2035-03-20→ American Depositary Shares representing Ordinary Shares (200,000 underlying)
Holdings
- 200
American Depositary Shares representing Ordinary Shares
Footnotes (3)
- [F1]Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.
- [F2]The stock option award was granted under the Issuer's 2023 Equity Incentive Plan. The stock option shall vest over four years from the grant date with 25% vesting on the 12 month anniversary of the grant date, and the remainder vesting ratably on a monthly basis over the then remaining 36 months from the grant date, such that it will be fully vested on the fourth anniversary of the grant date. The stock option award is subject to continued service with the Issuer.
- [F3]The stock option award was granted under the Issuer's 2023 Equity Incentive Plan. The stock options shall vest upon achievement of at least one of the following performance criteria: either (a) closing of a qualified financing of at least $15,000,000 in gross proceeds on or before December 31, 2025, or (b) closing of an antibody drug conjugate ("ADC") focused license transaction, with a minimum upfront payment of $10,000,000 on or before December 31, 2025. If neither of these criteria are met by December 31, 2025 the performance-based option will expire. The stock option award is subject to continued service with the Issuer.
Documents
Issuer
Akari Therapeutics Plc
CIK 0001541157
Entity typeother
Related Parties
1- filerCIK 0001983682
Filing Metadata
- Form type
- 4
- Filed
- Mar 23, 8:00 PM ET
- Accepted
- Mar 24, 5:00 PM ET
- Size
- 9.4 KB